A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Jul 2, 2020)
This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, the bill waives the required minimum proportion of low-income patients served for hospitals that began participating in the program during or prior to the COVID-19 emergency.
What just happenedJul 2, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4225-4226)
Who’s behind it
- Introduced in SenateJul 2, 2020
- Jul 2, 2020IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4225-4226)
Health, Education, Labor, and Pensions Committee - Jul 2, 2020IntroReferral10000
Introduced in Senate